Department of Pediatrics

January 2, 2014

Vanderbilt announces expansion plans for Monroe Carell Jr. Children’s Hospital

By John Howser
November 21, 2013

Ess named to take reins of Division of Pediatric Neurology

Kevin C. Ess, M.D., Ph.D., has been named chief of the Division of Pediatric Neurology within the Department of Pediatrics at the Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By Doug Campbell
November 7, 2013

Guttentag named to direct Neonatology

Susan H. Guttentag, M.D., is joining Vanderbilt University on Feb. 1, 2014, as the new director of the Division of Neonatology within the Department of Pediatrics at the Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By John Howser
October 28, 2013

Tool predicts risk for developmental delays in early childhood

A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study.

By Leigh MacMillan
October 17, 2013

VUMC joins national stroke prevention research network

Vanderbilt University Medical Center has joined a national network funded by the National Institutes of Health to streamline multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery.

By VUMC News and Communications
October 17, 2013

Fellow tracks post-vaccination bacterial trends

Pediatric Infectious Diseases fellow Annabelle de St. Maurice, M.D., has been awarded a grant to determine the relationship between pneumococcal vaccination and the emergence of certain strains of pneumococcal bacteria not covered by vaccines.

By VUMC News and Communications
September 26, 2013

Vaccine Research Program lands major NIH renewal

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units.
By VUMC News and Communications
September 19, 2013

VU testing vaccine against new flu threat

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring.
By VUMC News and Communications
September 19, 2013

Hyundai award helps drive hope for cancer research

Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer.
By Christina Echegaray
September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.
By VUMC News and Communications
September 12, 2013

Options to treat childhood C. diff. infection studied

After more than a month in and out of the hospital with her daughter, Kynslee, Kristen Allen felt she was at the end of her rope. Last spring, the nearly 2-year-old Columbia girl developed diarrhea that wouldn’t go away after taking antibiotics for repeated ear infections.
By VUMC News and Communications
September 12, 2013

‘Proofreader’ key to coronavirus growth

A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses.
By Leigh MacMillan
September 5, 2013

Webber delivers first State of Pediatrics address

By Christina Echegaray
1 … 45 46 47 48 49 … 55